University of California Irvine, Department of Medicine, Division of Infectious Diseases, 3501 Hewitt Hall, Irvine, CA 92697, USA.
Future Microbiol. 2010 Feb;5(2):241-51. doi: 10.2217/fmb.09.127.
A major component of the adaptive immune response to infection is the generation of protective and long-lasting humoral immunity. Traditional approaches to understanding the host's humoral immune response are unable to provide an integrated understanding of the antibody repertoire generated in response to infection. By studying multiple antigenic responses in parallel, we can learn more about the breadth and dynamics of the antibody response to infection. Measurement of antibody production following vaccination is also a gauge for efficacy, as generation of antibodies can protect from future infections and limit disease. Protein microarrays are well suited to identify, quantify and compare individual antigenic responses following exposure to infectious agents. This technology can be applied to the development of improved serodiagnostic tests, discovery of subunit vaccine antigen candidates, epidemiologic research and vaccine development, as well as providing novel insights into infectious disease and the immune system. In this review, we will discuss the use of protein microarrays as a powerful tool to define the humoral immune response to bacteria and viruses.
感染后适应性免疫反应的一个主要组成部分是产生保护性和持久的体液免疫。传统方法无法全面了解针对感染产生的抗体库。通过同时研究多种抗原反应,我们可以更多地了解针对感染的抗体反应的广度和动态。疫苗接种后抗体产生的测量也是疗效的指标,因为抗体的产生可以预防未来的感染并限制疾病的发生。蛋白质微阵列非常适合识别、定量和比较暴露于传染性病原体后个体的抗原反应。该技术可应用于改进血清诊断检测的开发、亚单位疫苗抗原候选物的发现、流行病学研究和疫苗开发,以及为传染病和免疫系统提供新的见解。在这篇综述中,我们将讨论使用蛋白质微阵列作为定义针对细菌和病毒的体液免疫反应的有力工具。